Treating Advanced Head and Neck Cancer When Cisplatin Is Not an Option

被引：4
作者：
Jhawar, Sachin R. [1 ,2 ]
Bonomi, Marcelo [3 ,4 ]
Harari, Paul M. [5 ]
机构：
[1] Ohio State Univ, Ctr Comprehens Canc, Dept Radiat Oncol, Arthur G James Canc Hosp, 460 West 10th Ave, Columbus, OH 43210 USA
[2] Ohio State Univ, Solove Res Inst, Ctr Comprehens Canc, 460 West 10th Ave, Columbus, OH 43210 USA
[3] Ohio State Univ, Ctr Comprehens Canc, Arthur G James Canc Hosp, Dept Med Oncol, Columbus, OH 43210 USA
[4] Ohio State Univ, Ctr Comprehens Canc, Arthur G James Canc Hosp, Solove Res Inst, Columbus, OH 43210 USA
[5] Univ Wisconsin, Dept Human Oncol, Sch Med & Publ Hlth, Madison, WI USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2021年 / 39卷 / 01期
关键词：
SQUAMOUS-CELL CARCINOMA; HUMAN-PAPILLOMAVIRUS; RADIATION-THERAPY; CHEMOTHERAPY; RADIOTHERAPY; CETUXIMAB; CHEMORADIOTHERAPY; FRACTIONATION;
D O I：
10.1200/JCO.20.02720
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
The Oncology Grand Rounds series is designed to place original reports published in the Journal into clinical context. A case presentation is followed by a description of diagnostic and management challenges, a review of the relevant literature, and a summary of the authors' suggested management approaches. The goal of this series is to help readers better understand how to apply the results of key studies, including those published in Journal of Clinical Oncology, to patients seen in their own clinical practice.
引用
收藏
页码：7 / 12
页数：6
相关论文
共 50 条
  • [21] Should Cetuximab Replace Cisplatin for Definitive Chemoradiotherapy in Locally Advanced Head and Neck Cancer?
    Riaz, Nadeem
    Sherman, Eric J.
    Fury, Matthew
    Lee, Nancy
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (02) : 287 - 288
  • [22] Two cases of combination therapy with cetuximab, paclitaxel, and cisplatin for advanced head and neck cancer
    Hoch, Matthew A.
    Cousins, Kati
    Nartey, Ruth
    Riley, Keith
    Hartranft, Megan
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2018, 24 (07) : 553 - 554
  • [23] Toxicity of daily low dose cisplatin in radiochemotherapy for locally advanced head and neck cancer
    Wolff, Hendrik Andreas
    Overbeck, Tobias
    Roedel, Ralph M.
    Hermann, Robert M.
    Herrmann, Markus K. A.
    Kertesz, Tereza
    Vorwerk, Hilke
    Hille, Andrea
    Matthias, Christoph
    Hess, Clemens F.
    Christiansen, Hans
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2009, 135 (07) : 961 - 967
  • [24] Altered-fractionated radiotherapy in locally advanced head and neck cancer
    Bernier, Jacques
    Horiot, Jean-Claude
    CURRENT OPINION IN ONCOLOGY, 2012, 24 (03) : 223 - 228
  • [25] WEEKLY 5-FLUOROURACIL PLUS CISPLATIN FOR CONCURRENT CHEMORADIOTHERAPY IN PATIENTS WITH LOCALLY ADVANCED HEAD AND NECK CANCER
    Lee, Young Joo
    Lee, Chang Geol
    Cho, Byoung Chul
    Kim, Gwi Eon
    Choi, Hye Jin
    Choi, Eun Chang
    Sohn, Joo Hyuk
    Kim, Joo-Hang
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2010, 32 (02): : 235 - 243
  • [26] Chemoradiation in Advanced Head and Neck Cancers: A Comparison of two Radiosensitizers, Paclitaxel and Cisplatin
    Kanotra, Sohit Paul
    Kanotra, Sonika
    Gupta, Ashutosh
    Paul, J.
    INDIAN JOURNAL OF OTOLARYNGOLOGY AND HEAD & NECK SURGERY, 2011, 63 (03) : 229 - 236
  • [27] Three weekly versus weekly concurrent cisplatin: safety propensity score analysis on 166 head and neck cancer patients
    Buglione, Michela
    Alterio, Daniela
    Maddalo, Marta
    Greco, Diana
    Gerardi, Marianna Alessandra
    Tomasini, Davide
    Pegurri, Ludovica
    Augugliaro, Matteo
    Marvaso, Giulia
    Turturici, Irene
    Guerini, Andrea
    Ansarin, Mohssen
    Spiazzi, Luigi
    Costa, Loredana
    Rocca, Maria Cossu
    Magrini, Stefano Maria
    Jereczek-Fossa, Barbara Alicja
    RADIATION ONCOLOGY, 2021, 16 (01)
  • [28] A randomized phase 3 trial comparing nimotuzumab plus cisplatin chemoradiotherapy versus cisplatin chemoradiotherapy alone in locally advanced head and neck cancer
    Patil, Vijay Maruti
    Noronha, Vanita
    Joshi, Amit
    Agarwal, Jaiprakash
    Ghosh-Laskar, Sarbani
    Budrukkar, Ashwini
    Murthy, Vedang
    Gupta, Tejpal
    Mahimkar, Manoj
    Juvekar, Shashikant
    Arya, Supreeta
    Mahajan, Abhishek
    Agarwal, Archi
    Purandare, Nilendu
    Rangarajan, Venkatesh
    Balaji, Arun
    Chaudhari, Sameer Vasant
    Banavali, Shripad
    Kannan, Sadhana
    Bhattacharjee, Atanu
    D'Cruz, Anil K.
    Chaturvedi, Pankaj
    Pai, Prathamesh S.
    Chaukar, Devendra
    Pantvaidya, Gouri
    Nair, Deepa
    Nair, Sudhir
    Deshmukh, Anuja
    Thiagarajan, Shivakumar
    Mathrudev, Vijayalakshmi
    Manjrekar, Aparna
    Dhumal, Sachin
    Maske, Kamesh
    Bhelekar, Arti Sanjay
    Nawale, Kavita
    Chandrasekharan, Arun
    Pande, Nikhil
    Goel, Alok
    Talreja, Vikas
    Simha, Vijai
    Srinivas, Sujay
    Swami, Rohit
    Vallathol, Dilip Harindran
    Dsouza, Hollis
    Shrirangwar, Sameer
    Turkar, Siddharth
    Abraham, George
    Thanky, Aditi Harsh
    Patel, Usha
    Pandey, Manish Kumar
    CANCER, 2019, 125 (18) : 3184 - 3197
  • [29] Undertreatment of women with locoregionally advanced head and neck cancer
    Park, Annie
    Alabaster, Amy
    Shen, Hanjie
    Mell, Loren K.
    Katzel, Jed A.
    CANCER, 2019, 125 (17) : 3033 - 3039
  • [30] Degree of nephrotoxicity after intermediate- or high-dose cisplatin-based chemoradiotherapy in patients with locally advanced head and neck cancer
    Driessen, Chantal M. L.
    Uijen, Maike J. M.
    van der Graaf, Winette T. A.
    van Opstal, Claudia C. M.
    Kaanders, Johannes H. A. M.
    Nijenhuis, Tom
    van Herpen, Carla M. L.
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2016, 38 : E1575 - E1581
12345